ReviewOncoTargets and therapy2022

PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components.

Geraldine O'Sullivan Coyne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.